REFERENCES
1. Dehghani Firouzabadi M, Dehghani Firouzabadi F, Goudarzi S, Jahandideh H, Roomiani M. Has the chief complaint of patients with COVID-19 disease changed over time? Medical Hypotheses.2020;144:109974.
2. Firouzabadi FD, Firouzabadi MD, Ghalehbaghi B, Jahandideh H, Roomiani M, Goudarzi S. Have the symptoms of patients with COVID-19 changed over time during hospitalization? Medical Hypotheses. 2020;143:110067.
3. Dehghani Firouzabadi F DFM, Ghalehbaghi B, Jahandideh H, Roomiani M, Goudarzi S, Moosaie F, Chi G. What is the difference between the first and second COVID-19 outbreak in Iran? International Journal of Cardiovascular Diseases & Diagnosis. 2020;In Press.
4. Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.Clinical Infectious Diseases. 2020.
5. Betoule A, Martinet C, Gasperini G, et al. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.J Thromb Thrombolysis. 2020;50(2):302-304.
6. Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. American Journal of Obstetrics and Gynecology. 2020;222(6):521-531.
7. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. (1538-7836 (Electronic)).
8. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147.
9. Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Critical Care.2020;24(1):360.
10. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet.2020;395(10229):1054-1062.
11. Dehghani Firouzabadi M, Goudarzi S, Dehghani Firouzabadi F, Moosaie F. Complete heart block and an itching rash in a patient with COVID-19.Caspian Journal of Internal Medicine. 2020.
12. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. (1538-7836 (Electronic)).
13. Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. Journal of Thrombosis and Haemostasis. 2020;18(7):1548-1555.
14. Martinelli I, Ferrazzi E, Ciavarella A, et al. Pulmonary embolism in a young pregnant woman with COVID-19. Thromb Res. 2020;191:36-37.
15. Di Mascio D, Khalil A, G S. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol 2020;2(2):100-107.